טוען...
Effects of erythropoietin on fibroblast growth factor 23 in mice and humans
BACKGROUND: Erythropoietin (EPO) has been reported as a novel determinant of fibroblast growth factor 23 (FGF23) production; however, it is unknown whether FGF23 is stimulated by chronic exposure to EPO or by EPO administration in nonpolycystic chronic kidney disease (CKD) models. METHODS: We analyz...
שמור ב:
| הוצא לאור ב: | Nephrol Dial Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6888066/ https://ncbi.nlm.nih.gov/pubmed/30007314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy189 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|